Related Experiment Videos
Nebulised sodium cromoglycate in the preschool wheezy child
Insights
Nebulised sodium cromoglycate effectively prevents exercise-induced bronchoconstriction in preschool children with recurrent wheezing. This treatment offers significant protection, similar to healthy children, for young patients.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
Background:
- Recurrent wheezing is common in preschool children.
- Exercise-induced bronchoconstriction (EIB) significantly impacts quality of life in affected children.
Purpose of the Study:
- To evaluate the efficacy of nebulised sodium cromoglycate in preventing EIB in preschool children.
- To assess the therapeutic potential of sodium cromoglycate in this age group.
Main Methods:
- A double-blind, controlled study involving 14 preschool children with recurrent wheezing.
- Administration of nebulised sodium cromoglycate versus nebulised water.
- Measurement of exercise-induced bronchoconstriction.
Main Results:
- All 14 children demonstrated reduced EIB after sodium cromoglycate treatment.
- 13 children showed protection levels comparable to healthy children.
- Nebulised water provided some protection in a subset of participants.
Conclusions:
- Nebulised sodium cromoglycate is an effective agent for inhibiting EIB in preschool children.
- The study supports the use of sodium cromoglycate for managing recurrent wheezing in children under five.
- Sodium cromoglycate offers significant therapeutic benefit for pediatric EIB.
Abstract:
A double-blind controlled study of 14 preschool children with recurrent wheezing episodes was performed to show the effectiveness of nebulised sodium cromoglycate in inhibiting exercise-induced bronchoconstriction in this age group. All 14 children showed markedly less exercise-induced bronchoconstruction after nebulised sodium cromoglycate, 13 of them to a degree indistinguishable from results obtained in normal healthy children in the same age group. Nebulised water afforded protection from exercise-induced bronchoconstriction in some children. This study gives further evidence that sodium cromoglycate is an effective therapeutic agent in children under the age of 5 years.